Inozyme Pharma Inc (INZY)
4.65
+0.05
(+1.09%)
USD |
NASDAQ |
May 02, 16:00
4.65
0.00 (0.00%)
After-Hours: 16:27
Inozyme Pharma Market Cap: 287.63M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 284.54M |
| April 30, 2024 | 272.78M |
| April 29, 2024 | 273.40M |
| April 26, 2024 | 274.64M |
| April 25, 2024 | 267.83M |
| April 24, 2024 | 272.16M |
| April 23, 2024 | 272.16M |
| April 22, 2024 | 271.55M |
| April 19, 2024 | 278.59M |
| April 18, 2024 | 282.92M |
| April 17, 2024 | 287.24M |
| April 16, 2024 | 299.59M |
| April 15, 2024 | 290.95M |
| April 12, 2024 | 317.51M |
| April 11, 2024 | 322.45M |
| April 10, 2024 | 323.69M |
| April 09, 2024 | 338.51M |
| April 08, 2024 | 362.60M |
| April 05, 2024 | 395.96M |
| April 04, 2024 | 400.90M |
| April 03, 2024 | 442.91M |
| April 02, 2024 | 428.08M |
| April 01, 2024 | 451.55M |
| March 28, 2024 | 473.17M |
| March 27, 2024 | 456.50M |
| Date | Value |
|---|---|
| March 26, 2024 | 418.81M |
| March 25, 2024 | 384.84M |
| March 22, 2024 | 358.28M |
| March 21, 2024 | 362.60M |
| March 20, 2024 | 365.07M |
| March 19, 2024 | 351.48M |
| March 18, 2024 | 370.63M |
| March 15, 2024 | 363.84M |
| March 14, 2024 | 347.16M |
| March 13, 2024 | 356.42M |
| March 12, 2024 | 353.34M |
| March 11, 2024 | 354.57M |
| March 08, 2024 | 392.25M |
| March 07, 2024 | 384.22M |
| March 06, 2024 | 371.85M |
| March 05, 2024 | 384.20M |
| March 04, 2024 | 386.67M |
| March 01, 2024 | 404.59M |
| February 29, 2024 | 392.85M |
| February 28, 2024 | 405.20M |
| February 27, 2024 | 422.50M |
| February 26, 2024 | 377.41M |
| February 23, 2024 | 352.70M |
| February 22, 2024 | 342.20M |
| February 21, 2024 | 348.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.41M
Minimum
Dec 30 2022
705.62M
Maximum
Sep 01 2020
287.13M
Average
259.32M
Median
Market Cap Benchmarks
| Xeris Biopharma Holdings Inc | 275.01M |
| Kodiak Sciences Inc | 194.38M |
| Phathom Pharmaceuticals Inc | 570.61M |
| Athira Pharma Inc | 75.12M |
| Disc Medicine Inc | 715.26M |
Market Cap Related Metrics
| Price to Book Value | 2.048 |
| Price | 4.65 |
| Earnings Yield | -29.89% |